RNA Interference News and Research

RSS
Scientists publish study results of AAV therapy product for treatment of RHO-adRP

Scientists publish study results of AAV therapy product for treatment of RHO-adRP

Scientists pinpoint key gene that controls body segmentation in spiders and insects

Scientists pinpoint key gene that controls body segmentation in spiders and insects

Scientists report novel gene therapy that halts vision loss in canine model of blinding disease

Scientists report novel gene therapy that halts vision loss in canine model of blinding disease

Researchers describe link between poor oocyte development and oxidative stress in obese mice

Researchers describe link between poor oocyte development and oxidative stress in obese mice

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

Researchers use DNA editing tool to reveal mechanisms behind autoimmune diseases

Researchers use DNA editing tool to reveal mechanisms behind autoimmune diseases

Researchers describe strategy used by Oropouche virus to replicate in human cells

Researchers describe strategy used by Oropouche virus to replicate in human cells

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Genes associated with autism interact to modulate variable symptoms of disease

Genes associated with autism interact to modulate variable symptoms of disease

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Researchers identify protein essential for eye lens development and clear vision

Researchers identify protein essential for eye lens development and clear vision

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Alnylam achieves delivery of novel siRNAs conjugates to the central nervous system

Alnylam achieves delivery of novel siRNAs conjugates to the central nervous system

New eye drop may be potentially effective in treating seasonal eye allergies

New eye drop may be potentially effective in treating seasonal eye allergies

Sylentis presents clinical study results of new treatment for dry eye syndrome

Sylentis presents clinical study results of new treatment for dry eye syndrome

New insight may allow researchers to design drugs that improve immune responses to vaccines

New insight may allow researchers to design drugs that improve immune responses to vaccines

Discovery of new ALS gene points to cytoskeleton as potential target for drug development

Discovery of new ALS gene points to cytoskeleton as potential target for drug development

Researchers use RNA nanotechnology to program exosomes for delivering effective cancer therapies

Researchers use RNA nanotechnology to program exosomes for delivering effective cancer therapies

Researchers discover potential regulator essential for killer T cells to reside in tumors

Researchers discover potential regulator essential for killer T cells to reside in tumors

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Texas Biomedical Research Institute tests promising new treatment for HBV infection